Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is a
refractory disease with many immune abnormalities and pathologies in the gastrointestinal …

Background The landscape of inflammatory bowel disease (IBD) treatment is rapidly
expanding with the development of new therapeutic options. Aim To review the mechanisms …

Hematopoietic stem cells (HSCs) exhibit considerable cell-intrinsic changes with age. Here,
we present an integrated analysis of transcriptome and chromatin accessibility of aged …

Ethnopharmacological relevance Baicalin (BI) is an important biologically active flavonoid
isolated from the root of Scutellaria radix (Huang Qin). Traditionally Scutellaria radix was the …

The etiology of inflammatory bowel disease (IBD) is extremely complex and related to an
excessive immune response that results in the pathologically release of reactive oxygen …

Crohn's disease (CD) and ulcerative colitis (UC), two components of inflammatory bowel
disease (IBD), are painful conditions that affect children and adults. Despite substantial …

Recently an outbreak that emerged in Wuhan, China in December 2019, spread to the
whole world in a short time and killed> 1,410,000 people. It was determined that a new type …

Inflammatory bowel disease (IBD) is a chronic immune-mediated condition of the
gastrointestinal tract that requires chronic treatment and strict surveillance. Development of …

Inflammatory bowel disease (IBD) is characterized by chronic and relapsing intestinal
inflammation, which currently lacks safe and effective medicine. Some previous studies …

Ulcerative colitis (UC) is a common clinical inflammatory bowel disease characterized by
repeated attacks, difficult treatment, and great harm to the physical and mental health of the …